SCHEMBL31435485

SCHEMBL31435485

N#CC1CNCC(c2ccccc2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 2/20 0.42
CHRNA3 P32297 2/20 0.42
SLC18A3 Q16572 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
DPP4 P27487 2/20 0.39
KDM1A O60341 2/20 0.38
MAOA P21397 1/20 0.38
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
CHRNB2 P17787 3/20 0.37
CHRNA4 P43681 3/20 0.37
CHRNA1 P02708 1/20 0.37
CHRNG P07510 1/20 0.37
CHRNB1 P11230 1/20 0.37
CHRND Q07001 1/20 0.37
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
SLC6A4 P31645 1/20 0.35
MAOB P27338 1/20 0.35
HDAC2 Q92769 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26302859 1.00 CHRNB4 (0.42) CHRNB4CHRNA3SLC18A3SIGMAR1DPP4
SCHEMBL26302858 1.00 CHRNB4 (0.42) CHRNB4CHRNA3SLC18A3SIGMAR1DPP4
SCHEMBL17241088 0.83 CHRNB4 (0.35) CHRNB4CHRNA3DPP4CHRNB2CHRNA4
SCHEMBL23647061 0.82 CHRNB4 (0.42) CHRNB4CHRNA3SLC18A3SIGMAR1KDM1A
SCHEMBL22209814 0.81 GAA (0.43) SLC18A3SIGMAR1DPP4KDM1AMAOA
SCHEMBL12809152 0.79 GAA (0.42) SLC18A3SIGMAR1DPP4KDM1AMAOA
SCHEMBL233570 0.76 SLC18A3 (0.58) CHRNB4CHRNA3SLC18A3SIGMAR1KDM1A
SCHEMBL10177659 0.76 AKR1C3 (0.47) SLC18A3SIGMAR1DPP4GAAMAPT
Hydrochloric Acid SCHEMBL557175 0.74 SLC18A3 (0.56) CHRNB4CHRNA3SLC18A3SIGMAR1KDM1A
SCHEMBL25409399 0.73 MEN1 (0.39) DPP4KDM1AMAOAGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179103-A1 6-OXODECAHYDROPYRROLO[1,2-A][1,5]DIAZOCINE AND 6-OXODECAHYDRO-4H-PYRROLO[2,1-D][1,5]THIAZOCINE DERIVATIVES AS STAT3 AND STAT6 MODULATORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS RECLUDIX PHARMA, INC. 2025-06-05 US disclosed
CN-119301127-A 6-Oxo-decahydro pyrrolo [1,2-a ] [1,5] diazocine and 6-oxo-decahydro-4H-pyrrolo [2,1-d ] [1,5] thiaazacine derivatives as modulators of STAT3 and STAT6 for the treatment of cancer and inflammatory conditions 瑞克鲁迪克斯制药股份有限公司 2025-01-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250179103-A1 6-OXODECAHYDROPYRROLO[1,2-A][1,5]DIAZOCINE AND 6-OXODECAHYDRO-4H-PYRROLO[2,1-D][1,5]THIAZOCINE DERIVATIVES AS STAT3 AND STAT6 MODULATORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS STAT6, STAT3, STAT1 CHRNB4 4828/4885CHRNA3 4748/4885SLC18A3 4883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.